Today news
The same in other media
Covid drugs aid IPM's rebound to double-digit growth in March; sustenance is key
Reading now: 956
growth reported by the Indian pharma market (IPM) in the month of March should bring cheers to investors. Reports indicate that IPM grew 10.3% year-on-year (y-o-y) in the month of March 2021 as compared to 1.1% in February 2021, and 8.9% in March 2020.The growth though was aided by the low base of last year to an extent.
Nevertheless, analysts are of the view that not all is being driven by the low base but significant recovery in the pharma market.Also Read | The silent rise of India’s private portsAmong the key growth drivers, according to analysts, was the pricing that added 5.1% to the growth in March 2021.
The new product launches and volume growth also helped. New product launches contributed 3.6% to the sector's growth. The remaining.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|